Diet and relapsing ulcerative colitis: Take off the meat?

Gut

Volumn 53, Issue 10, 2004, Pages 1399-1401

  Tilg, H ^a   Kaser, A ^b  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIOXIDANT; BUTYRIC ACID; ESSENTIAL FATTY ACID; FISH OIL; HYDROGEN SULFIDE; IRON; NITROGEN; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYUNSATURATED FATTY ACID; PREBIOTIC AGENT; REACTIVE OXYGEN METABOLITE;

ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; BIFIDOBACTERIUM; DIET SUPPLEMENTATION; DIETARY FIBER; DIETARY INTAKE; DISEASE COURSE; ENTERITIS; EUBACTERIUM; FERMENTATION; HUMAN; LACTOBACILLUS; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MEAT; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INTAKE; RELAPSE; REMISSION; ULCERATIVE COLITIS;

BUTYRATES; COLITIS, ULCERATIVE; DIET; HUMANS; HYDROGEN SULFIDE; MEAT; PROBIOTICS; RECURRENCE;

EID: 4644290608     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.035287     Document Type: Note

References (37)

1. Jowett SL, Seal CJ, Pearce MS, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 2004;53:1479-84.
2. Bitton A, Peppercorn MA, Antonioli DA, et al. Clinical, biological, and histological parameters as predictors of relapse in ulcerative colitis. Gastroenterology 2001;120:13-20.
3. Russel MG, Engels LG, Muris JW, et al. Modern life in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol 1998;10:243-9.
4. Reif S, Klein I, Lubin F, et al. Pre-illness dietary factors in inflammatory bowel disease. Gut 1997;40:754-60.
5. Geerling BJ, Dagnelie PC, Badart-Smook A, et al. Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol 2000;95:1008-13.
6. Levitt MD, Furne J, Springfield J, et al. Detoxification of hydrogene sulfide and methanethiol in the cecal flora. J Clin Invest 1999;104:1107-14.
7. Richardson CJ, Magee EA, Cummings JH. A new method for the determination of sulphide in gastrointestinal contents and whole blood by microdistillation and ion chromatography. Clin Chim Acta 2000;293:115-25.
8. Magee EA, Richardson CJ, Hughes R, et al. Contribution of dietary protein to sulphide production in the large intestine: an in vitro and a controlled feeding study in humans. Am J Clin Nutr 2000;72:1488-94.
9. Roediger WEW, Morre J, Babidge W. Colonic sulfide in the pathogenesis and treatment of ulcerative colitis. Dig Dis Sci 1997;42:1571-9.
10. Roediger WEW. Decreased sulphur aminoacid intake in ulcerative colitis. Lancet 1998;351:1555.
11. Chapman MA, Grahn MF, Boyle MA, et al. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 1994;35:73-6.
12. Pitcher MC, Beatty ER, Cummings JH. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut 2000;46:64-72.
13. Christl SU, Eisner HD, Dusel G, et al. Antagonistic effects of sulphide and butyrate on proliferation of colonic mucosa: a potential role for these agents in the pathogenesis of ulcerative colitis. Dig Dis Sci 1996;41:2477-81.
14. Suarez FL, Fume JK, Springfield J, et al. Bismuth subsalicylate markedly decreases hydrogen sulphide release in the human colon. Gastroenterology 1998;114:932-9.
15. Roediger WE, Duncan A, Kapaniris O, et al. Reducing sulphur compounds of the colon impairs colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 1993;104:802-9.
16. Venkatraman A, Ramakrishna BS, Shaji RV, et al. Amelioration of dextrane sulphate colitis by butyrate: role of heat shock protein 70 and NF-kappaB. Am J Physiol Gastrointest Liver Physiol 2003;285:G177-84.
17. Kinoshita M, Suzuki Y, Saito Y. Butyrate reduces colonic paracellular permeability by enhancing PPAR gamma activation. Biochem Biophys Res Commun 2003;293:827-31.
18. Tanaka T, Kohno H, Yoshitani S, et al. Ligands for peroxisome proliferators-activated receptors α and γ inhibit chemically induced colitis and formation of aberrant crypt foci in rats. Cancer Res 2001;61:2424-8.
19. Den Hond E, Hiele M, Evenepoel P, et al. In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. Gastroenterology 1998;115:584-90.
20. Scheppach W, Christl SU, Batram HP, et al. Effects of short-chain fatty acids on the inflamed colonic mucosa. Scand J Gostroenterol Suppl 1997;222:53-7.
21. Vernia P, Annese V, Bresci G, et al. Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest 2003;33:244-8.
22. Hallert C, Bjorck I, Nyman M, et al. Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm Bowel Dis 2003;9:116-21.
23. Goh J, O'Morain CA. Nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther 2003;17:307-20.
24. Kanauchi O, Suga T, Tochihara M, et al. Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial. J Gastroenterol Suppl 2002;14:67-72.
25. Mitsuyama K, Saiki T, Kanauchi O, et al. Treatment of ulcerative colitis with germinated barley foodstuff feeding: a pilot study. Aliment Pharmcaol Ther 1998;12:1225-30.
26. Kanauchi O, Serizawa I, Araki Y, et al. Germinated borley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environment. J Gastroenterol 2003;38:134-41.
27. Fernandez-Banares F, Hinojosa J, Sanchez-Lombrana JL, et al. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Am J Gostroenterol 1999;94:427-33.
28. Rodriguez-Cabeza ME, Galvez J, Camuesco D, et al. Intestinal anti-inflammatory activity of dietary fiber (Plantago ovata seeds) in HLA-B27 transgenic rats. Clin Nutr 2003;22:463-71.
29. Lorenz R, Weber PC, Szimnau P, et al. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease; a randomised, placebo-controlled, double-blind cross-over trial. J Intern Med Suppl 1989;225:225-32.
30. Stenson WF, Cort D, Rodgers J, et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 1992;116:609-14.
31. Hawthorne AB, Daneshmend TK, Hawkey CJ, et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 1992;33:922-928.
32. Aslan A, Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, cross-over study. Am J Gastroenterol 1992;87:432-37.
33. Greenfield SM, Green AT, Teare JP, et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment Pharmacol Ther 1993;7:159-66.
34. Middleton SJ, Naylor S, Woolner J, et al. A double-blind, randomised, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis. Aliment Pharmacol Ther 2002;16:1131-5.
35. D'Odorico A, Bortolan S, Gardin R, et al. Reduced plasma antioxiclant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 2001;36:1289-94.
36. Kruidenier L, Kuiper I, Lamers CB, et al. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 2003;201:28-36.
37. Carrier J, Aghdassi E, Platt I, et al. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther 2001;15:1989-99.